Perspective Therapeutics, Inc. (CATX)

NYSEAMERICAN: CATX · Real-Time Price · USD

2.930

-0.010 (-0.34%)

At close: Jun 16, 2026, 4:00 PM EDT

2.924

-0.006 (-0.20%)

After-hours: Jun 16, 2026, 8:00 PM EDT

Perspective Therapeutics Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2022
Period Ending	Jun '26 Jun 16, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Jun '22 Jun 30, 2022
Market Cap	334	204	225	113	35	44
Market Cap Growth	75.13%	-9.32%	99.00%	222.74%	-20.02%	-61.24%
Enterprise Value	67.46	62.95	2.59	106.6	-8.66	-11.48
Last Close Price	2.93	2.75	3.19	4.02	2.47	3.09
PS Ratio	540.70	231.26	155.05	79.00	-	-
PB Ratio	0.96	0.99	0.78	1.51	0.64	0.72
EV/Sales Ratio	109.15	71.21	1.78	74.34	-	-
EV/EBITDA Ratio	-	-	-	-	1.00	1.87
EV/EBIT Ratio	-	-	-	-	1.00	1.79
EV/FCF Ratio	-	-	-	-	-	1.44
Debt / Equity Ratio	0.01	0.01	0.01	0.03	0	0.00
Net Debt / Equity Ratio	-0.77	-0.68	-0.77	-0.09	-0.80	-0.90
Net Debt / EBITDA Ratio	2.29	1.28	2.52	0.17	5.05	9.03
Net Debt / FCF Ratio	2.49	1.49	3.07	0.18	-	6.94
Asset Turnover	0.00	0.00	0.01	0.02	0	0
Quick Ratio	8.61	5.05	12.45	0.66	16.43	25.37
Current Ratio	8.75	5.17	12.68	1.07	17.07	26.18
Return on Equity (ROE)	-40.09%	-41.44%	-43.34%	-71.65%	-17.63%	-11.30%
Return on Assets (ROA)	-35.42%	-37.07%	-40.34%	-49.66%	-13.50%	-9.52%
Return on Invested Capital (ROIC)	-93.83%	-97.32%	-89.18%	-79.28%	-104.92%	-110.77%
Return on Capital Employed (ROCE)	-38.87%	-40.47%	-44.87%	-59.68%	-14.03%	-9.82%
Buyback Yield / Dilution	-16.38%	-14.57%	-140.72%	-88.39%	-0.06%	-316.28%
Total Shareholder Return	-16.38%	-14.57%	-140.72%	-88.39%	-0.06%	-316.28%

SEC Filings: 10-K · 10-Q